Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Open accessThe DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
: 1. After 50 years of antipsychotic drug development focused on the dopamine D2 receptor, schizophrenia remains a chronic, disabling disorder for most affected individuals. 2. Studies over the last decade demonstrate that administration of low doses of NMDA receptor antagonists can cause in normal subjects the negative symptoms, cognitive impairments and physiologic disturbances observed in schizophrenia. 3. Furthermore, a number of recently identified risk genes for schizophrenia affect NMDA receptor function or glutamatergic neurotransmission. 4. Placebo-controlled trials with agents that directly or indirectly activate the glycine modulatory site on the NMDA receptor have shown reduction in negative symptoms, improvement in cognition and in some cases reduction in positive symptoms in schizophrenic patients receiving concurrent antipsychotic medications. 5. Thus, hypofunction of the NMDA receptor, possibly on critical GABAergic inter-neurons, may contribute to the pathophysiology of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overactivity of NMDA receptors causing excitotoxicity is a proposed underlying mechanism for epilepsy, dementia, and stroke, whereas low activity produces symptoms of schizophrenia.2–4”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The prefrontal cortex (PFC) and hippocampus stand out as major regions affected in schizophrenia”
From Adolescent Onset of Cortical Disinhibition in Schizophrenia: Insights From Animal Models (2011) · cites this paper as [3]
In the citing paper
“A loss of scaffolding proteins in spines could alter glutamatergic receptor signaling, disruption of which is theorized to contribute to the etiology of schizophrenia60.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [60]
In the citing paper
“Overactivity of NMDA receptors causing excitotoxicity is a proposed underlying mechanism for epilepsy, dementia, and stroke, whereas low activity produces symptoms of schizophrenia.2–4”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · cited 1×
“Existing drugs are poorly tolerated and exhibit little differences in efficacy (Lieberman et al., 2005).”
BackgroundKrystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · cited 2×
“Newcomer et al. (1999) extended the findings of Krystal et al. (1994) by showing that declarative memory, the form impaired in schizophrenia, was quite sensitive to low dose ketamine infusion.”
BackgroundRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · cited 1×
“Based upon the emerging pharmacology of the NMDAR, Javitt and Zukin (1991) proposed that the psychotomimetic effects of PCP were due to blockade of the NMDA receptors.”
BackgroundTripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 1×
“The glutamatergic synapse consists of a tight functional relationship among the presynaptic terminal, the postsynaptic spine and the ensheathing astrocyte end-foot (Araque et al., 1999; Coyle et al., 2002).”
BackgroundSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The hippocampal-VTA loop: controlling the entry of information into long-term memory
Lisman, J. E., & Grace, A. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.002 · Cited by 1,983
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · cited 2×
“In addition, clozapine treatment has been associated with reduction in the rate of suicide, reduction in smoking and reduction in abuse of other substances in schizophrenic patients (Drake et al., 2000; Meltzer et al., 2003; Zimmet et al., 2000).”
BackgroundLesion of striatal neurons with kainic acid provides a model for Huntington's chorea
COYLE, J. T., & SCHWARCZ, R. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,248 · cited 1×
“We focused on glutamatergic signal transduction before there was any evidence that it could be relevant to neuropsychiatric disorders (Coyle and Schwarcz, 1976).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Wang, X., He, G., Gu, N., Yang, J., Tang, J., Chen, Q., et al. (2004). Association of G72/G30 with schizophrenia in the Chinese population. Biochem. Biophys. Res. Commun. 319:1281–1286. · DOI
Cited by
Items 901–954 of 954
The GRIA1 AMPA receptor subunit and selective learning
Strickland, J. A., Austen, J. M., Sprengel, R., & Sanderson, D. J. (2025) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2025.108089
Ghumman, M., Furderer, M., & Beri, K. (2024) · Journal of Student Research · doi:10.47611/jsrhs.v13i4.8195
Roalf, D. R., Moore, T. M., Stifelman, J., Pecsok, M. K., Atkins, A., Baller, E. B., Calkins, M. E., Biasi, M. D., Kohler, C. G., Mastracchio, C., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03705-1
“Glutamatergic alterations are central to the pathophysiology of psychosis [28], as evidenced by a growing literature [29, 30], including data from animal models [31 – 35], postmortem studies [36 – 39], genetic analyses [40 – 44], peripheral biomarkers [45], and in vivo 1 HMRS [20, 23, 46].”
Early Postnatally Induced Conditional Reelin Deficiency Causes Malformations of Hippocampal Neurons
Lódi, M., Ahrari, A., Meseke, M., Corvace, F., Kümmel, M.-L., Trampe, A.-K., Hamad, M. I. K., & Förster, E. (2025) · Biomolecules · doi:10.3390/biom15121662 · Cited by 2
THERAPEUTIC POTENTIAL OF CREATINE IN PSYCHIATRY: FROM NEUROBIOLOGY TO CLINICAL APPLICATIONS
Gnitecki, S., Wasiak, J., Zielonka, K., Dądela, B., Markowski, M., Śliwa, N., Jakubowska, D., Kawalska, E., Janczura, S., & Borowski, M. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.4586
Samuelsson, M. (2012) · DiVA (Digitala Vetenskapliga Arkivet)
Katsouni, E. (2021) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-de9nj7bqe
Strellis, B. (2025) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.84922
Dostal, C. (2018) · Common Library Network (Der Gemeinsame Bibliotheksverbund) · doi:10.22032/dbt.38228
EXPLORING OXYTOCIN’S CONTRIBUTIONS TO NEUROPSYCHIATRICCONDITIONS AND ADDICTIVE STATES
Rodriguez, K. M. (2020) · OhioLink ETD Center (Ohio Library and Information Network)
Fernández, M. M. (2023) · UNED repository · Cited by 1
Svensson Andersen, J., & Brisbo, E. (2024) · University Library of Skövde (University of Skövde)
A novel postsynaptic role for DDC in synaptic plasticity in the adult mammalian hippocampus
Thompson‐Steckel, G. (2014) · eScholarship@McGill (McGill) · doi:10.82308/32127 · Cited by 1
Gas-Prades, C. (2021) · Rovira & Virgili repository
Oxitocina, potencial ferramenta terapêutica para a esquizofrenia e outros estados neuropsiquiátricos
Ramos, J. B. C. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Peralta-Vallejo, N. (2024) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Deciphering Amotivation in Schizophrenia: A Bayesian Computational Analysis of Exploratory Behaviour
Yang, Y. (2024) · TSpace (University of Toronto)
Torres‐Carmona, E. (2025) · TSpace (University of Toronto)
Lu, C., Li, S., Zhang, X., Han, Y., Wang, L., Sun, W., Zhang, C., Wang, S., Li, S., Li, J., et al. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02221-1
“Furthermore, positive symptoms are associated with abnormal enhancement of glutamatergic excitatory neurotransmission, while cognitive impairments are more closely related to dysfunction in glutamatergic pathways [55–57].”
Rôle de la reelin dans la plasticité des structures stratifiées du système nerveux central
Campo, C. G. (2009) · theses.fr (ABES) · doi:10.70675/12218853zd74dz4229zb940z380b72a15278
Rôle du trafic des récepteurs NMDA au cours de la maturation et plasticité synaptique
Ladépêche, L. (2012) · theses.fr (ABES) · doi:10.70675/e7e86d96z75e5z4319zb956zdb5e0c1dd525 · Cited by 1
The Role of Motivation and Emotion in the Hippocampal Navigation System
Forro, T., & Ciocchi, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-20563-6_11
Giannitelli, M. (2016) · theses.fr (ABES) · doi:10.70675/0819e96ez67b3z4a38zb7dcz6776c2a1ef7e
Battal-Merlet, L. (2019) · theses.fr (ABES) · doi:10.70675/7e556f24z8bd5z4c89z8632zb1f371c1f12d
Responsiveness and dynamics of asynchronous states and Gamma oscillations in cerebral cortex
Susin, E. (2021) · theses.fr (ABES) · doi:10.70675/45a9917bz0609z450azbd4bz82094b558df6
Rogóż, Z., & Wąsik, A. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00853-7
“According to the dopaminergic and glutamatergic hypotheses of schizophrenia, it has been suggested that glutamate dysregulation in cortical areas, including the hippocampus, causes dysfunction of dopaminergic neurons in the striatum, leading to the development of psychotic symptoms [ 11–15 ].”
Antipsychotic effects of aqueous lyophilisate of Ficus mucuso on ketamine-induced schizophrenia
Moto, F. C. O., DIAPA, J. T., Njapdounké, J. S. K., Mbom, A., Savo, F. M., Aren, M. N. A., Nezoumne, F. N., Ndjock, R. S., & Bum, E. N. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1788148
Ćmok, Ł., Dobrowolska, J., Chudy, J., Skalski, J. R., Daniel, G., Halat, K., Hajdas, A., Kaczmarczyk, N., Kałka, I., & Szmuc, J. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.5596
Cerebrovascular Disease and Cognitive Function
Teng, Z. (2026) · Wiley eBooks · doi:10.1002/9781394278886.ch03 · Cited by 1
Adolescent Δ9-THC Exposure Differentially Affects Mice Depending on Their Personality
Begmatova, D., Vinnikova, L., Zemliana, N. A., Blum, K., Thanos, P. K., Kogan, N. M., & Pinhasov, A. (2026) · Pharmaceuticals · doi:10.3390/ph19071009
“Schizophrenia has been increasingly associated with glutamatergic dysfunction, particularly hypofunction of NMDA receptors [26,27].”
Consciousness and psychiatric disorders
Northoff, G., Lechner, S., & Arantes-Gonçalves, F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29258-3.00041-0
Characteristic Analysis of the Resting-State fMRI Global Signal in Schizophrenia
Yang, Z., Chang, X., Chen, J., Pei, H., Liao, J., Luo, X., He, H., Duan, M., Rodríguez-Labrada, R., Jiang, S., et al. (2026) · International Journal of Neural Systems · doi:10.1142/s0129065727500080
Murano, T. (2019) · Institutional Repositories DataBase (IRDB)
A Graph-Theoretical and MRS-Based Mathematical Model of Glutamatergic Dysfunction in Schizophrenia
Çevik, D. G. B., Analan, M. E., & Büyükköse, Ş. (2026) · Advances in Linear Algebra & Matrix Theory · doi:10.4236/alamt.2026.163003
Beyond dopamine: KarXT and emerging mechanism-based therapies in schizophrenia
Żuraw, I., Urbański, K., Kogut, P., Pańczyszyn-Trzewik, P., & Sowa-Kućma, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1828831
N-Acetylcysteine in Schizophrenia: A Convergent Redox-Based Approach to Therapeutic Potential
Rubio-Contreras, E., Pérez‐Toribio, A., Alvaro, P., Cosialls, A. M., & Morén, C. (2026) · Antioxidants · doi:10.3390/antiox15101277
“These oscillations contribute to acute synaptic plasticity and longer-term structural adaptations [41,45].”
A Review on Role of Neurotransmitters in Psychiatric Disorders: Pharmacological Interventions.
Kumar, A., Kumar, A., & Kumar, A. (2025) · Journal of Drug Discovery and Therapeutics
Rodríguez, A. (2020) · Repositorio Digital de la UNC (National University of Cordoba)
BindingDB (2010) · UC San Diego · doi:10.7270/q2z31zr5
BindingDB (2014) · UC San Diego · doi:10.7270/q2571dfr
Vunck, S. A. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/xrap-zd09
Chen, J. (2014) · UNM’s Digital Repository (University of New Mexico)
Regulation and Pharmacological Manipulation of the Type 5 Metabotropic Glutamate (mGlu5) Receptor
Bradley, S. J. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Campbell, A. D. (2010) · The Knowledge Bank (The Ohio State University)
Metadata
- Authors
- Coyle, J. T.
- Affiliations
- Harvard University (US)
- Corresponding author
- Coyle, Joseph T.
- ORCID
- Coyle, Joseph T.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2006-06-14
- Volume
- 26
- Issue
- 4-6
- Pages
- 363-382
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11881825
- OpenAlex
- W2008639041
- Cited by
- 917
- References
- 159
- Citations by year
- 2026: 13 · 2025: 27 · 2024: 16 · 2023: 29 · 2022: 29 · 2021: 28 · 2020: 35 · 2019: 47 · 2018: 43 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 47 · 2013: 74 · 2012: 62
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (P50MH060450, MH P50-60450, MH R01-572901)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, glutamate, NMDA receptor, dopamine hypothesis, negative symptoms, cognitive impairment, NMDA receptor antagonists, schizophrenia risk genes, GABAergic interneurons, antipsychotic drugs, glutamatergic neurotransmission
- MeSH terms
- Animals, Dopamine, Glutamates, Humans, Models, Biological, Synaptic Transmission, Schizophrenia, Antipsychotic Agents, Receptors, N-Methyl-D-Aspartate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.